Trial Profile
Safety, feasibility and performance of everolimus-eluting bioresorbable vascular scaffolds (BVS) in patients with ST-elevation myocardial infarction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 16 Dec 2015 New trial record